4//SEC Filing
Lawton Alison Frances 4
Accession 0001628280-21-011543
CIK 0001501697other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:02 PM ET
Size
5.8 KB
Accession
0001628280-21-011543
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-02$9.50/sh+6,000$57,000→ 6,000 totalExercise: $9.50Exp: 2031-06-02→ Common Stock (6,000 underlying)
Footnotes (1)
- [F1]8.3333% of the shares subject to the option shall vest on July 2, 2021, with the remainder vesting in equal monthly installments of 8.333% of the shares subject to the option until the 12-month anniversary of the date of the grant (or, if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant) subject to the Reporting Person continuing to provide services through each such date.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001542650
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 5:02 PM ET
- Size
- 5.8 KB